Maternal-Fetal Medicine (Jan 2024)

Clinical Management Guidelines for Intrahepatic Cholestasis of Pregnancy

  • Yang Pan,
  • Obstetrics Group of the Gynecology and Obstetrics Branch of Chinese Medical Association; Perinatal Medicine Branch of Chinese Medical Association,
  • Xinyang Yu,
  • Huixia Yang,
  • Hongbo Qi,
  • Hongbo Qi,
  • Huixia Yang,
  • Xinghui Liu,
  • Jing He,
  • Xinyang Yu,
  • Yaolong Che,
  • Yali Hu,
  • Xiaotian Li,
  • Yumei Wei,
  • Yin Zhao,
  • Wei Zhou,
  • Yayi Hu,
  • Xiaodong Wang,
  • Yan Gao,
  • Yangyu Zhao,
  • Dunjin Chen,
  • Jianying Yan,
  • Ling Feng

DOI
https://doi.org/10.1097/fm9.0000000000000207
Journal volume & issue
Vol. 6, no. 1
pp. 13 – 22

Abstract

Read online

Abstract. Intrahepatic cholestasis of pregnancy (ICP) is a significant gestational complication in late pregnancy, potentially leading to severe perinatal complications such as intrauterine fetal demise and preterm birth. The Obstetrics Group of the Gynecology and Obstetrics Branch and the Perinatal Medicine Branch of the Chinese Medical Association organized a panel of domestic experts to deliberate and propose recommendations based on domestic and international guidelines, recent evidence-based medical evidence about key clinical issues including risk factors, clinical manifestations, perinatal outcomes, diagnosis, severity grading, maternal and fetal monitoring, treatment methods, timing, and methods of pregnancy termination, and postpartum follow-up for ICP, with the aim to guide its clinical diagnosis, treatment, and management.